Extremely high rates of squamous cell carcinoma of the esophagus (SCCE) are observed in Iran, re¯ecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations in SCCE, TP53 mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5 ± 8) in 98 SCCE from Iran by temporal temperature gel electrophoresis and direct sequencing. We found 58 mutations in 49 patients (50%), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was signi®cantly dierent from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007). Moreover, the prevalence of mutations at A : T base pairs (transitions and transversions) was higher in men than in women (38.7% vs 11.1%, P=0.033). COX-2 overexpression was detected in 69% of the cases evaluated (24/35), without signi®cant association with TP53 mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess levels of nitric oxide, was observed in tumor cells in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis in Iran. These factors include a baseline of chronic in¯ammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk. Oncogene (2001) 20, 7368 ± 7374.
Introduction
Squamous cell carcinoma of the esophagus (SCCE) shows striking geographic variations in incidence, which are thought to re¯ect genetic and/or epidemiological risk factors (reviewed in MunAE oz and Day (1996) ). The highest rates in the world have been reported in central China (Henan and Shanxi Provinces) and in the so-called`central Asian esophageal cancer belt' which includes parts of northern Iran, Kazakhstan, Uzbekistan, Turkmenistan and northern Afghanistan (Kmet and Mahboubi,1972; Mahboubi et al., 1973) . A recent prevalence survey carried out in northern Iran has con®rmed these observations (Saidi et al., 2000) . In this area, both sexes show agestandardized incidence rates (ASR) of over 100/100 000 person-years (165.5 in men and 195.3 in women, (Mahboubi et al., 1973) . This is in contrast with industrialized countries, where SCCE occurs mostly in males and where ASR does not exceed 10 ± 30/100 000.
The factors responsible for these geographic variations are poorly understood. In most Western countries, tobacco and alcohol are the major etiologic factors. In other areas, suspected factors include thermal irritation, dietary factors and nutritional de®ciencies in antioxidants and in oligoelements such as zinc (MunAE oz and Day, 1996) . In northern Iran, positive associations have been found with low socioeconomic status and low intake of fruits and vegetables. Tobacco chewing (nass), a widespread habit in central Asia, does not appear to make a signi®cant contribution. In contrast, opium dross has been identi®ed as a factor of risk in the Caspian littoral area, where the incidence rates are the highest (CookMozaari et al., 1979; Hewer et al., 1978; Hormozdiari et al., 1975) .
The pathogenesis of SCCE is accompanied by multiple genetic alterations, the most frequent of which is mission missense of the tumor suppressor gene TP53 (Hollstein et al., 1991; Montesano et al., 1996) . TP53 mutation pro®les in SCCE vary signi®cantly from one geographic area to the other (TanieÁ re et al., 2000) . These pro®les may reveal clues to the molecular mechanisms involved in mutagenesis and carcinogenesis (Hainaut and Hollstein, 2000) .
Overexpression of cyclooxygenase-2 (COX-2) is common in in¯ammatory tissues and is associated with tumor progression in various cancers including SCCE (Ratnasinghe et al., 1999; Shamma et al., 2000; Zimmermann et al., 1999) . In vitro experiments have demonstrated that p53 downregulates the COX-2 promoter (Subbaramaiah et al., 1999) . Recent ®ndings suggest an association between missense mutations in TP53 and overexpression of COX-2 in gastric cancers (Leung et al., 2001) .
During the in¯ammatory process, large quantities of NO are produced by inducible nitric oxide synthase (iNOS), which is often expressed in in¯amed tissues (Ohshima and Bartsch, 1994) . The reaction product of NO with superoxide is peroxynitrate (ONOO 7 ), a potent nitrating agent which reacts with tyrosine in proteins to form a stable product. Detection of nitrotyrosine can thus be used as a marker for detection of protein damage resulting from high levels of NO production (Chazotte-Aubert et al., 2000) . Presence of nitrotyrosine has been recently reported in SCCE of Japanese patients, suggesting that production of NO increases in these cancers, as a result of chronic in¯ammation in response to stress induced by exogenous factors of risk (Kato et al., 2000) .
In this study, we have analysed the pattern of TP53 mutations in 98 SCCE specimens collected in Iran. In addition, we have analysed the expression of COX-2 by immunohistochemistry in a subset of these tumors. We have also used antibodies to nitrotyrosine as a marker of damage in¯icted by NO in 18 cancer cases as well as in adjacent, non-involved esophageal mucosa.
Results
Ninety-eight primary, invasive squamous cell carcinomas of the esophagus were analysed in patients who underwent resection between 1991 ± 1998 in three central hospitals in Tehran (Iran-Mehr, Madaen and Modarress). The patients included 59 males and 39 females (mean age: 58 years, range 27 ± 86). The prevalence of TP53 mutations was 50% (49/98). In these 49 tumors, a total of 58 TP53 mutations were detected (Table 1) . One tumor had three mutations, and seven tumors had two mutations. Fifty point mutations were detected, including four silent mutations, six nonsense mutations, four silent mutations and eight frameshift mutations were detected. There were no new hotspots, although seven mutations (12%) were found at codon 175, one of the major hotspots for mutation in human cancer. Only two mutations were detected at codon 273, and none at codon 248, the two other most frequently mutated codons in other cancers.
The pattern of mutations showed a high prevalence of C to T transitions (25/58, 43%), most of them at CpG dinucleotides (17/58, 29.3%) followed by mutations at A : T base pairs (both transitions and transversions, 15/58, 25.8%) ( Table 2 ). The C to T transitions at CpG dinucleotides were more common in females than in males (37.0% vs 22.5%, P=NS), while the mutations at A : T base pairs were more common in males than in females (38.7% vs 11.1%, P=0.01). Gender dierences for other types of mutations were not signi®cant (Table 2) .
In Table 3 , we compare the pattern of TP53 mutations in Iran with those of areas of Western Europe and China with high incidence of esophageal squamous cell carcinomas (data selected from the IARC TP53 mutation database, with criteria as described in Materials and methods). Overall, the three patterns of TP53 mutations were signi®cantly dierent (Pearson's w 2 =34.29, P=0.0001, 10 dF). C to T transitions at CpG dinucleotides were signi®cantly higher in Iran and in China than in Western Europe (29.3% and 23.9%, vs 10.4%, respectively) ( Table 3) . A signi®cantly higher prevalence of transitions and transversions at A : T base pairs was also found in patients from Western Europe compared to those from China (46.8% vs 15%, Fisher's exact=0.001) ( Table  3) .
Expression of COX-2 was studied by immunohistochemistry in 35 of the 98 cases, all from Iran-Mehr Hospital (data not shown, results summarized in Table  4 ). We found that 24 tumors (69%) expressed COX-2 in at least 10% of the tumor cells. Expression of COX-2 was not signi®cantly correlated with TP53 mutation.
Presence of nitrotyrosine was investigated in 18 tumors and in adjacent, non-involved mucosa ( Figure  1 ). Nitrotyrosine staining was detected in stromal cells, in in®ltrated in¯ammatory cells and in endothelial cells in all tumors analysed. Cytoplasmic nitrotyrosine staining was observed in at least 10% of epithelial cancer cells in six cases (30%), ®ve of which were also positive for COX-2 overexpression. Moreover, several islets of nitrotyrosine-positive epithelial cells were detectable in adjacent, non-involved esophageal mucosa in two cases ( Figure 2c ). Together, the results of studies on COX-2 expression and nitrotyrosine staining are suggestive of the involvement of chronic in¯ammatory stress and high levels of NO production in the pathogenesis of esophageal cancers in Iran.
Discussion
In the north-east of the Caspian Littoral of Iran, the age-adjusted incidence rate of esophageal cancer is higher than reported for any site by any registry (Mahboubi et al., 1973a) . Although reliable incidence data are lacking, Tehran is not considered a part of the regions of highest incidence for SCCE in this country. However, as the three hospitals involved in the study are nationwide centers for esophageal cancer, the patients enrolled originate not only from Tehran city but also from various urban and rural locations throughout Iran. The male to female ratio (60 ± 40%) in our study population is consistent with the gender pattern of the high incidence areas, where the females are highly aected (see Introduction). However, it should be noted that the highest risks of SCCE are observed among the Turkoman population of northern Iran, and that most of the patients analysed here were not of Turkoman descent. Therefore, we believe that the mutation pattern reported here corresponds to a general description of the TP53 mutation pattern in SCCEs from Iran, rather than to the speci®c pattern of the areas of highest incidence. We found that the prevalence of TP53 mutations was 50%, similar to the one observed in high-incidence areas of China, Thailand and northern Italy. Much higher prevalences (over 80%) have been reported in the west part of France (Audrezet et al., 1993; Robert et al., 2000) . The two most frequent types of mutations observed in the present study, C to T transitions at CpG dinucleotides (29.3%) and mutations at A : T base pairs (both transitions and transversions) (25.8%) are frequent in most types of cancers. They represent 24% and 20%, respectively, of all TP53 mutations in primary tumors compiled in the IARC TP53 database. Transitions at CpG dinucleotides often occur through endogenous mutational mechanisms resulting from spontaneous deamination of methylated cytosine to generate thymine. This process is enhanced by exposure to nitric oxide, and CpG transitions have been observed at a high frequency in cancers associated with chronic in¯ammatory states, such as adenocarcinomas of the esophagus (48%), colon (41%) and stomach (35%) (Ambs et al., 1999; Hainaut and Hollstein, 2000) . Their high prevalence in this study may therefore re¯ect the role of multiple forms of stress and of chronic in¯ammation in the pathogenesis of SCCE, and is consistent with our observations that COX-2 expression and nitrotyrosine staining are often elevated in these cancers. The mutations at A : T base pairs are consistent with a mutagenic mechanism involving acetaldehyde, a primary metabolite of ethanol. We and others have proposed that their high prevalence in Western Europe may re¯ect the predominant role of alcohol in esophageal carcinogenesis in this region (TanieÁ re et al., 2000; Robert et al., 2000) . However, it should be noted that metabolites of benzo(c)phenanthrene, one of the main carcinogens in opium pyrolysates, may also induce transversions or transitions at A : T base pairs (Friesen et al., 1985; Harsch et al., 2000) . Unfortunately, no reliable data are available on individual exposure of Iranian patients to these potential risk factors.
The overall high rates of mutations at CpG dinucleotides in both males and females suggest that a baseline in¯ammatory process may be involved in the development of SCCE in Iran. The high incidence of A : T base pairs mutations in the male population, possibly due to the eects of opium metabolites and/or acetaldehyde, suggests that additional, exogenous factors of risk, might be also incriminated. Although opium and alcohol consumption are legally and religiously prohibited, their use even in a small fraction of a population with a`baseline' in¯ammatory load may have a multiplicative eect on the risk of esophageal cancer. The observed dierences between the mutation patterns of three high incidence areas, Iran, western Europe and China, con®rms that the etiological mechanisms involved in disease causation and progression may be dierent from one area to the other.
High levels of COX-2 have often been shown to be associated with tumor progression in various cancers, including SCCE (Ratnasinghe et al., 1999; Shamma et al., 2000; Zimmermann et al., 1999) . Deregulation of COX-2 expression is a common phenomenon in response to physical and chemical stress, in¯ammation or hypoxia (Fosslien, 2000) . Interestingly, overexpression of COX-2 is more frequent in tumors from Iran than in SCCE from other areas. Using the same method, we have observed a signi®cantly lower prevalence of COX-2 over-expression in SCCE from a low-incidence area of south-eastern France (69% vs 42%, P=0.031) (TanieÁ re et al., 2001a) . Compatible with these ®ndings, nitrotyrosine staining was detectable in in®ltrated and endothelial cells in all tumors tested, as well as in epithelial cancer cells in 30% of the cases. Moreover, we found that, in two cases, islets of nitrotyrosine-positive cells were present in the noninvolved mucosa adjacent to cancer, suggesting that protein damage by high levels of NO can occur in the normal mucosa at an early stage of the tumorigenic process. In a recent study of nitrotyrosine staining in SCCE from Japan, Kato et al. (2000) found elevated staining in 38.2% of tumors, but adjacent, noninvolved epithelium was consistently negative.
While this study was in preparation, another study on 74 cases of SCCE collected in Iran (40 cases from Tehran and 34 cases from unspeci®ed locations in north-eastern townships of the Caspian Sea) was published (Biramijamal et al., 2001) . Our observations are in agreement with theirs regarding the high prevalence of CpG transitions in the Iranian population. However, their ®ndings do not con®rm the high rates of A : T base pair mutations in men and the existence of a gender bias. It should be noted that their series of patients included more women than men and that 67% of the mutations they identi®ed were in women. Another point of disagreement between the two studies is the prevalence of transversions. We did not observe less transversions in SCCE from Iran than in other areas. The dierence between transversions in Iran compared to the IARC TP53 mutation database reported by Biramaijamal et al. (2001) stems from grouping all transversions (at A : T or G : C base pairs) in a single group, irrespective of sex and of geographic origin of the tumors. As shown in Table 3 , there are no dierences in the prevalence of transversions on G bases between specimens from Iran and from Western Europe, and there is no signi®cant dierence in the prevalence of transversions at A : T base pairs between Iran and Western Europe if sex distribution is taken into account.
Overall, our results support the hypothesis that in Iran, dierent mechanisms may be responsible for TP53 mutagenesis in esophageal cancers. Thus, the high risk of SCCE in Iran cannot be assigned to a single causative agent. We suggest that this risk may result from the concerted action of several forms of physical and chemical stresses which cooperate to create a selection pressure favoring the emergence of clonal cell populations with mutant TP53. The nature of the mutation may vary according to the in¯amma-tory state and the carcinogenic exposures speci®c to each gender, in relation with dierences in a number of socio-cultural habits such as tobacco smoking, alcohol drinking and consumption of opium. The high prevalence of COX-2 and nitrotyrosine staining overexpression adds further support to this`multiple stress' hypothesis. Moreover, there is experimental evidence that COX-2 inhibitors exert anti-proliferative eects on esophageal cancer cells (Zimmermann et al., 1999) . Given the poor survival rate of SCCE, it would be worthwhile investigating chemopreventive approaches targeting COX-2 to manage the risk of esophageal cancer in high incidence areas of central Asia.
Materials and methods

DNA extraction
Invasive squamous cell carcinoma of the esophagus (ICDO code C15.9; 8070/3) collected at surgery were ®xed in 10% p53 mutations and esophageal cancer in Iran A Sepehr et al buered formalin and embedded in paran. Archived blocks from hospital pathology collections were used. As most of the patients died before the study, individual informed consent forms were not available. The specimens were anonymous and handled according to the ethical guidelines of the Council for International Organization of Medical Sciences (1993). Tissues were ®xed in 10% neutral buered formalin and embedded in paran. Areas of tumor cells were selected, microdissected and used for DNA extraction as described elsewhere (TanieÁ re et al., 2001a,b) . Brie¯y, material scraped from the slides was extracted in 50 ml of extraction buer (10 mM/l of Tris-HCl, 1 mM EDTA, pH 9, 0.1 mg/ml proteinase K, 0.25% Nonidet P40). Samples were incubated for 3 days at 568C adding 2 ml of proteinase K twice a day, followed by inhibition of proteinase K at 958C for 10 min.
Analysis of TP53 mutations
TP53 exons 5 ± 8 (containing over 90% of all mutations identi®ed so far in SCCE) (Hernandez-Boussard et al., 1999) were analysed by Temporal Temperature Gradient Electrophoresis (TTGE) using the DCode system (BioRad, Richmond CA, USA) and the primers described elsewhere (TanieÁ re et al., 2000 (TanieÁ re et al., , 2001 . DNA was ampli®ed in a DNA thermocycler (Perkin Elmer, Norwalk, CT, USA) in a 50 ml reaction mixture containing 5 ml of genomic DNA, 20 pmol of sense and anti-sense primers, 200 mM of each dNTP, 1 x ampli®cation buer, 16Q solution and 0.5 ml (2.5 units) of Taq polymerase (HotStar Taq DNA Polymerase, Qiagen, Hilden, Germany). PCR conditions were: 15 min at 958C followed by 35 ± 40 cycles at 958C (1 min), 568C (exons 5 proximal, 6, 8) or 628C (exons 5 distal, and 7) (1 min), 728C (1 min). The reaction was ended by a 10 min extension at 728C. Heteroduplex formation was induced by denaturation for 10 min at 988C, followed by 30 min at the annealing temperature. TTGE was run at 130 V at temperatures optimised for each DNA fragment (exon 5p: 56 ± 708C; exon 5d: 63 ± 708C; exon 6: 58 ± 708C; exon 7: 59 ± 708C; exon 8: 53 ± 678C; ramp rates of 2 or 38C). Negative controls (wildtype sample) and positive controls (known mutants) were included in each run. Samples that showed additional/ abnormal bands were re-ampli®ed from genomic DNA and a second TTGE was performed for con®rmation. Bands corresponding to mutant alleles were cut from the second gel and analysed by either direct manual sequencing after asymmetric PCR ampli®cation as previously described (Barnas et al., 1997) or by microcapillary electrophoresis using an ABI 310 genetic analyser (PE Biosystems, Foster City, CA, USA). All results were con®rmed by a second, independent sequence analysis using the same primers.
TP53 mutations from other high incidence areas of the world
Data from the IARC TP53 mutation database (version R4, 14051 entries, http://www.iarc.fr/p53) were used. TP53 mutations in exons 5 ± 8 of primary, invasive squamous cell carcinomas of the esophagus (SCCE) were selected. All the reported mutations from pre-malignant lesions, carcinomas in situ and cell lines were excluded. Two areas were selected for comparison: high incidence areas of Western Europe (northern Italy (Esteve et al., 1993; Rugge et al., 1997) ; Brittany and Normandy, France (Audrezet et al., 1993; Hollstein et al., 1991; Robert et al., 2000) ) and central China (Henan and Shanxi Provinces (Cai et al., 2000; Gao et al., 1994; Liang et al., 1995; Shi et al., 1996 Shi et al., , 1999 ; Martel-Planche and TanieÁ re, unpublished data). Data from a report by Lung et al. (1996) were not included as this publication reports a`hotspot' mutation which has not been con®rmed in subsequent studies. Therefore, it is possible that this ®nding may represent a laboratory artefact, or an unusual feature restricted to a particular category of patients.
COX-2 and nitrotyrosine immunohistochemistry
Rehydrated tissue sections were exposed overnight at 48C to the anti-COX-2 polyclonal antibody C-20, (1/1000, Santa Cruz Biotechnology) or to the polyclonal antibodies against NTYR (1/500, Upstate Biotechnology). Fixed antibodies were detected using biotinylated anti-rabbit IgG (1/200 Vectasin Elite-ABC kit, Vector Laboratories Inc.) followed by streptavidin-peroxidase and diaminobenzidine-based detection according to standard protocols (Vector Laboratories, Inc.). Tumors with more than 20% stained cancer cells were considered as positive.
Statistical analysis
Pearson's w 2 analysis and Fisher's exact test were applied to compare nominal variables, using SAS Software, version 6, Cary, NC, USA. Level of signi®cance was established at P40.05.
